Skye Bioscience Stock Quote SKYE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.21

Bid

2.55

Ask

3.21

Volume

5,143,769

2.9501 Day's Range 3.50

3.06 52 Week Range 17.6473

Market Cap

97.386M

Previous Close

5.49

Open

3.16

Last Trade

200

3.21

(formt)

Last Trade Time

Financial Volume

$ 15,950,154

VWAP

3.1009

Average Volume (3m)

221,070

Shares Outstanding

30,338,290

Dividend Yield

PE Ratio

-10.32

Earnings Per Share (EPS)

-1.24

Revenue

152k

Net Profit

-37.65M

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The compan... Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The company's lead compound, SBI-100, is initially being developed to treat ocular disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

skyebioscience.com

Headquarters

Carson City, Nevada, USA

Founded

Skye Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SKYE. The last closing price for Skye Bioscience was $5.49. Over the last year, Skye Bioscience shares have traded in a share price range of $ 3.06 to $ 17.6473.

Skye Bioscience currently has 30,338,290 shares outstanding. The market capitalization of Skye Bioscience is $166.56 million. Skye Bioscience has a price to earnings ratio (PE ratio) of -10.32.

Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity

BOSTON and SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in at-home sleep monitoring and computational neurodiagnostics, today announced a strategic collaboration with...

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.923986	-47.6686122205	6.133986	6.22	3.06	126387	5.61359582	CS
4	-2.06	-39.0891840607	5.27	7.47	3.06	148431	6.15744587	CS
12	-3.79	-54.1428571429	7	8.36	3.06	221070	6.24709214	CS
26	-10.29	-76.2222222222	13.5	17.6473	3.06	183182	7.80830435	CS
52	-10.29	-76.2222222222	13.5	17.6473	3.06	183182	7.80830435	CS
156	-10.29	-76.2222222222	13.5	17.6473	3.06	183182	7.80830435	CS
260	-10.29	-76.2222222222	13.5	17.6473	3.06	183182	7.80830435	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BNZIBanzai International Inc	$ 5.645 (96.01%)	61.39M
ZJYLJin Medical International Ltd	$ 3.975 (50.00%)	1.24M
ANEBAnebulo Pharmaceuticals Inc	$ 2.9001 (39.43%)	78.85k
XPONExpion360 Inc	$ 0.081 (39.18%)	1.46B
AENTAlliance Entertainment Holding Corporation	$ 2.74 (34.31%)	4.23M
GSIWGarden Stage Ltd	$ 1.34 (-82.89%)	26.44M
CRBPCorbus Pharmaceuticals Holdings Inc	$ 19.51 (-62.26%)	12.29M
LGCBLinkage Global Inc	$ 0.4183 (-57.70%)	2.16M
BFIBurgerFi International Inc	$ 0.0855 (-42.27%)	15.05M
SKYESkye Bioscience Inc	$ 3.17 (-42.26%)	5.14M
XPONExpion360 Inc	$ 0.081 (39.18%)	1.46B
NVDANVIDIA Corporation	$ 116.00 (-1.59%)	377.84M
AAPLApple Inc	$ 228.20 (-0.29%)	320.78M
INTCIntel Corporation	$ 21.84 (3.31%)	261.68M
VERBVerb Technology Company Inc	$ 0.0742 (33.45%)	178.65M